Cite
HARVARD Citation
Cheung, D. et al. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary pharmacology & therapeutics. p. . [Online].